Print Friendly, PDF & Email

NCT/Study#

NCT04577807 /

LUMINOS-102

PVSRIPO with and without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma

DISEASE GROUP:
Skin and Soft Tissue
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: